InspireMD seeks to utilize its proprietary MicroNetâ¢ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events. Note: Underwriter indicated date is not firm
Last Closing Price
February 27, 2018
H.C. Wainwright & Co.
To view the prospectus for InspireMD, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277